OptimizeRx to Present at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021
February 16 2021 - 7:31AM
OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of
digital health solutions for life science companies, physicians and
patients, has been invited to present at the SVB Leerink 10th
Annual Global Healthcare Conference being held virtually on
February 22-26, 2021.
OptimizeRx CEO, William Febbo, is scheduled to present on
Thursday, February 25, at 5:00 p.m. Eastern time and will
participate in virtual one-on-one meetings with institutional
analysts and investors throughout the conference.
The presentation will be webcast live and available for replay
here and via the investor relations section of the company’s
website at www.optimizerx.com.
Management will discuss the company’s recently reported record
preliminary results for the fourth quarter and full year 2020. The
company expects fourth quarter 2020 revenue up 117% to record $16
million, driving full year revenue up 75% to record $43
million.
These record preliminary results are largely driven by life
science companies increasingly using the company’s nationwide
digital health network to engage providers and patients at key
touchpoints along the care journey.
Register for the conference here. To schedule a one-on-one
meeting, please contact your SVB Leerink representative. For any
questions about OptimizeRx, please contact Ron Both of CMA at (949)
432-7557 or submit your request here.
About SVB LeerinkSVB Leerink is a leading
investment bank, specializing in healthcare and life sciences. The
firm’s knowledge, experience and focus enable it to help its
clients define and achieve their strategic, capital markets and
investment objectives. SVB Leerink partners with companies that
develop and commercialize innovative products and services that are
defining the future of healthcare. SVB Leerink LLC is a member of
SVB Financial Group and is a member of FINRA/SIPC. For more
information, visit www.svbleerink.com.
About OptimizeRxOptimizeRx is a digital
health company that provides communications solutions for life
science companies, physicians and patients. Connecting over half of
healthcare providers in the U.S. and millions of patients
through a proprietary network, the OptimizeRx digital
health platform helps patients afford and stay on medications. The
platform unlocks new patient and physician touchpoints for life
science companies along the patient journey, from point-of-care, to
retail pharmacy, through mobile patient engagement.
Important Cautions Regarding Forward-Looking
Statements Certain information contained in this press
release includes “forward-looking statements” within the meaning of
The Private Securities Litigation Reform Act of 1995, including
statements related to the gross proceeds we expect to receive from
the offering, the expected use of the net proceeds from the
offering and the expected date of the closing of the offering. We
may, in some cases use terms such as “expects,” “plans,” “will” or
other words that convey uncertainty of the future events or
outcomes to identify these forward-looking statements. Our
forward-looking statements are based on current expectations that
involve risks, potential changes in circumstances, assumptions and
uncertainties. Any or all of the forward-looking statements may
turn out to be wrong, or be affected by inaccurate assumptions we
might make or by known or unknown risks and uncertainties as a
result of various important factors, including the uncertainties
related to market conditions and the completion of the public
offering on the anticipated terms, or at all. For a further
description of the risks and uncertainties that could cause actual
results to differ from those expressed in these forward-looking
statements, as well as risks relating to our business in general,
please refer to our preliminary prospectus supplement filed with
the Securities and Exchange Commission (SEC) on February 8, 2021
under the heading “Risk Factors” and those documents incorporated
by reference therein, which includes our Annual Report on Form 10-K
filed with the SEC on March 26, 2020. You are cautioned not to
place undue reliance on these forward-looking statements, which are
made only as of the date of this press release. We undertake no
obligation to publicly update such forward-looking statements to
reflect subsequent events or circumstances.
OptimizeRx ContactDoug Baker, CFOTel (248)
651-6568
x807dbaker@optimizerx.com
Media Relations Contact Maira Alejandra,
Media Relations ManagerTel (754)
245-7070 malejandra@optimizerx.com
Investor Relations ContactRon Both, CMATel
(949)
432-7557oprx@cma.team
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
From Aug 2024 to Sep 2024
OptimizeRx (NASDAQ:OPRX)
Historical Stock Chart
From Sep 2023 to Sep 2024